Private Advisor Group, LLC Harrow Health, Inc. Transaction History

Private Advisor Group, LLC

  • $15.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
BUY
$8.5 - $12.0 $1,462 - $2,064
172 Added 1.27%
13,683 $118,000
Q3 2021

Oct 14, 2021
BUY
$6.99 - $10.6 $14,455 - $21,920
2,068 Added 18.07%
13,511 $123,000
Q2 2021

Aug 12, 2021
BUY
$6.68 - $11.07 $9,191 - $15,232
1,376 Added 13.67%
11,443 $106,000
Q1 2021

Apr 22, 2021
BUY
$6.26 - $11.03 $63,019 - $111,039
10,067 New
10,067 $68,000

Others Institutions Holding HROW

# of Institutions
176
Shares Held
21.4M
Call Options Held
845K
Put Options Held
717K
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.06B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email